Harvia Oyj
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HRVFF research report →
Price Chart
About the company
Harvia Oyj, along with its subsidiaries, specializes in the production and worldwide distribution of a comprehensive selection of saunas, encompassing traditional, steam, and infrared designs. The company's broad product lineup includes fundamental sauna components like various heaters (electric and wood-burning), fully constructed sauna rooms, premium hot tubs, sophisticated control units, and robust steam generators. Furthermore, Harvia supplies a wide array of complementary items, such as sauna heater spare parts, specific sauna stones, elements for steam rooms, infrared components, advanced sound and lighting systems, and water purification products.
- CEO
- Matias Jarnefelt
- IPO
- 2021
- Employees
- 735
- HQ
- Muurame, CF, FI
Get TickerSpark's AI analysis on HRVFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $915.63M
- P/E
- 28.40
- Fwd P/E
- 27.42
- PEG
- 1.33
- P/S
- 3.85
- P/B
- 6.13
- EV/EBITDA
- 17.83
- Div Yield
- 1.75%
- Gross Margin
- 44.49%
- Op Margin
- 19.25%
- Net Margin
- 13.52%
- ROE
- 21.82%
- ROIC
- 13.16%
Latest fiscal year · YoY change
- Revenue
- $198.90M+13.5%
- Gross Profit
- $127.67M+13.4%
- Op Income
- $38.30M
- Net Income
- $26.44M+9.1%
- EPS
- $1.41+8.5%
- OCF Growth
- +10.4%
- FCF Growth
- -20.9%
- 52W High
- $51.90
- 52W Low
- $37.95
- 50D MA
- $49.89
- 200D MA
- $45.85
- Beta
- 1.27
- RSI (14)
- 29
- Avg Volume
- 15
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Harvia posted double-digit Q2 revenue growth driven by North America, but Muurame’s IT/process upgrade delayed about EUR 4 million of deliveries and temporarily दबressed margins and cash flow.· August 6, 2026
- Revenue rose 11.7% year on year to EUR 52.8 million, with all growth organic.
- Adjusted operating profit was EUR 8.6 million, or 16.2% of revenue, below usual levels because deliveries were postponed during the Muurame systems transition.
- North America was the standout region, with revenue up nearly 40% in euros and above 40% in local currency, led by sauna cabins and D2C growth.
- Management said roughly EUR 4 million of Q2 deliveries were pushed into later periods, with the majority expected in Q3.
- The company returned close to normal operations by end-Q2 and expects full operational capacity in Q3, while still investing in Lewisburg, IT, and R&D.
Q2 revenue increased 11.7% year on year to EUR 52.8 million, with comparable-currency growth close to 13% and all growth organic. Adjusted operating profit was EUR 8.6 million, equal to 16.2% of revenue. Operating free cash flow was EUR 3.1 million in Q2, and first-half revenue was around EUR 111 million, up roughly 12%, with adjusted operating profit of EUR 21 million (19.3% margin) and operating free cash flow of EUR 15.1 million. Management said about EUR 4 million of deliveries were delayed from Q2 into later periods, and expects the majority to show up in Q3. Full-year guidance was not given as a formal range, but management reiterated long-term targets of 10%+ average annual revenue growth, over 20% adjusted operating profit margin, and leverage below 2.5; it also said the Gulf region could have about a 1% impact on full-year group growth, with about EUR 2 million at risk for the year.
Matias Jarnefelt framed the quarter as a mix of strong underlying demand and a deliberate operational reset. He emphasized that the Muurame IT/process upgrade should make Harvia more scalable and productive over time, even though it temporarily hit top line and profit, and he said the company was close to normal operations by the end of Q2 and expects full capacity in Q3. He was upbeat about North American momentum, product innovation, and Harvia’s role in expanding the sauna/wellness category through research, design awards, and digital capabilities.
Ari Vesterinen highlighted the seasonality of the business and said Q2 was pressured by the roughly EUR 4 million shipment delay tied to the heater production pause and transition in Muurame. He noted headcount increased by 64 employees, 59 of them in the U.S., and said net working capital stayed high because inventory was built up in Finland ahead of the catching-up period and winter season. He also said leverage remains well below the 2.5 long-term target, giving the company room for possible acquisitions, while CapEx typically runs at least 4% to 5% of annual revenue and the board approved EUR 0.77 per share in dividends for last year, with EUR 0.39 paid in April and the remainder planned for October 2026.
Analysts focused on whether the EUR 4 million of delayed Q2 deliveries is secured for Q3; management said it is not guaranteed but expects the majority to be delivered in Q3, with some slippage still possible. Questions also centered on North America, where management said growth came mainly from existing channels and strong D2C performance, while mix shifted toward lower-margin sauna cabins versus technical products. Analysts pressed on steam sales weakness and ThermaSol; management said the category is slower-growing, was hurt by Gulf-region disruption and competitive pressure, but still has long-term potential and multiple corrective actions underway. Management also said tariffs and the Middle East situation are manageable relative to prior disruptions, and that any tariff refunds would be only small amounts.
The positive case is that demand appears strong, especially in North America, where sauna cabin demand, D2C, and existing channels are scaling well. Management believes the operational issues were temporary, with Q3 and Q4 benefiting from restored capacity, catch-up shipments, and improved scalability from the Muurame and Lewisburg investments. The company also sees long-term upside from product innovation, category-building efforts, and a broader wellness strategy.
The main risks on this call were execution-related: the Muurame system transition delayed deliveries, reduced profitability, and lifted inventory/working capital. Regional weakness remains in Northern Europe, Continental Europe, APAC and the Middle East, with the Gulf situation still affecting project business and management estimating about EUR 2 million of annual revenue at risk. Steam is also a concern, as management admitted the business is not growing as desired and faces slower market growth plus competitive pressure.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 81.0%
- Shares Outstanding
- 18.69M
- Float Shares
- 15.13M
Our HRVFF coverage
Recent articles, reports, and earnings notes.
No research on HRVFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HRVFF report →Harvia Oyj (HRVFF) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 6
Harvia: A Hidden European Growth Story With A Powerful Replacement Flywheel
seekingalpha.com · Jul 13
Harvia Oyj (HRVFF) Q1 2026 Earnings Call Transcript
seekingalpha.com · May 7
Harvia Oyj: Acquisition of own shares on February 20, 2026
globenewswire.com · Feb 20
Harvia Oyj: Acquisition of own shares on February 19, 2026
globenewswire.com · Feb 19
Harvia Oyj (HRVFF) Q4 2025 Earnings Call Transcript
seekingalpha.com · Feb 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.